Benefits Of Lyme disease research
in primary care setting

Lyme disease patients benefit directly from the research conducted at the Lyme Disease Practice and Research (LDPR) center. Through LDPR, patients gain access to clinical trials by the same doctors who are treating them, and they are often among the first to receive new, proven therapies for their disease.

The primary care setting is uniquely relevant to chronic Lyme disease epidemiology, given the availability of frontline personnel treating Lyme disease, the ability to examine the entire cohort of Lyme disease patients, and the potential for conducting rapidly evolving or emergent research.

Research in a primary care practice resolves methodological problems, such as documenting the accuracy of a customary procedure in preparation for use in epidemiologic research (referral bias), or evaluating the effect of Lyme disease diagnosis and/or treatment on risk factor estimates derived from case-control studies. The control population drawn from the same primary care practice in an endemic area for Lyme disease allows generalizability to the primary care setting.

The Lyme Disease Practice and Research center envisions piloting new therapeutic clinical trials that move new treatment strategies more rapidly from the primary care office to peer-reviewed journals and medical conferences.

To contact, Dr. Daniel Cameron for research projects, click below.

Request Research Study Participation

Overview of LDPR

In addition to his writing and clinical work, Dr. Cameron conducts epidemiological research through the Lyme Disease Practice & Research (LDPR) center, located at his private practice in Mount Kisco, New York …more  

LDPR Clinical Trials

Dr. Daniel Cameron, an internist and epidemiologist, has been actively involved in clinical research as a principle investigator in the tick-borne illness field and as a sub-investigator for leading pharmaceutical companies. Several of his key research projects are listed below. more  

Published Papers

Dr. Daniel Cameron has published more than 30 scientific papers, covering a range of topics in the tick-borne disease field. Many papers have been featured in lectures in the United States, Europe and Canada …more